Evidence map›Paper›PMID 39827108›Full record

ArticleBMC public health2025

Evaluation of the adherence of municipalities and states to the Ministry of Health's microplanning for high-quality vaccination activities and the increase in vaccination coverage in Brazil.

Ana Catarina de Melo Araújo, Thales Philipe Rodrigues da Silva, Gustavo Velasquez-Melendez, Luciana Maiara Diogo Nascimento, Carla Conceição Ferraz, Fernanda Penido Matozinhos, Eder Gatti Fernandes

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana Catarina de Melo AraújoCoordenadora-Geral de incorporação cientifica e Imunização, Ministério da Saúde Secretaria de Vigilância em Saúde e Ambiente, Departamento de Doenças Imunopreveníveis, Coordenação-Geral de Incorporação Cientifica e Imunizações, Doutora em Enfermagem pela Universidade Estadual de Pernambuco, Brasília, Brazil.
Thales Philipe Rodrigues da SilvaDoutor em Ciências da Saúde - Saúde da Criança e do Adolescente pela Faculdade de Medicina da UFMG. Residente Pós-doutoral pelo programa de Pós-graduação em Enfermagem da EE UFMG. Departamento de Enfermagem na Saúde da Mulher. Escola Paulista de Enfermagem - EPE, Universidade Federal de São Paulo - UNIFESP. Vice-líder do grupo de Pesquisa OPESV - Observatório de Pesquisa e Estudos em Vacinação, São Paulo, Brazil.
Gustavo Velasquez-MelendezDoutor em Saúde Pública, Universidade Federal de Minas Gerais, Escola de Enfermagem, Departamento de Enfermagem Materno-Infantil e Saúde Pública. Bolsista de Produtividade em Pesquisa do CNPq - Nível 1C. Programa de Pós-Graduação em Enfermagem - EEUFMG. Membro do grupo de Pesquisa OPESV - Observatório de Pesquisa e Estudos em Vacinação, Belo Horizonte, Brazil.
Luciana Maiara Diogo NascimentoMinistério da Saúde Secretaria de Vigilância em Saúde e Ambiente, Departamento de Doenças Imunopreveníveis, Coordenação-Geral de Incorporação Cientifica e Imunizações, Brasília, Brazil.
Carla Conceição FerrazMinistério da Saúde Secretaria de Vigilância em Saúde e Ambiente, Departamento de Doenças Imunopreveníveis, Coordenação-Geral de Incorporação Cientifica e Imunizações, Brasília, Brazil.
Fernanda Penido MatozinhosDoutora em Saúde e Enfermagem, Universidade Federal de Minas Gerais, Escola de Enfermagem, Departamento de Enfermagem Materno-Infantil e Saúde Pública. Bolsista de Produtividade em Pesquisa - CNPq, Programa de Pós-Graduação em Enfermagem e em Ciências da Saúde na Faculdade de Medicina da UFMG. Líder do grupo de Pesquisa OPESV - Observatório de Pesquisa e Estudos em Vacinação, Belo Horizonte, Brazil. nandapenido@hotmail.com.
Eder Gatti FernandesDiretor do Programa Nacional de Imunizações, Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente, Departamento de Doenças Imunopreveníveis, Doutor em Saúde Coletiva pela Faculdade de Medicina da Universidade de São Paulo - FMUSP, Brasília, Brazil. eder.gatti@saude.gov.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmunization is a significant public health achievement for the whole world, although the population's adherence to vaccination efforts remains a concern. To address this, Brazil's Ministry of Health introduced the concept of operational microplanning (OM) for high-quality vaccination activities (HQVA) in 2023 to ensure excellence in routine service and campaigns. OM is defined by structured interventions using assertive techniques to enhance the likelihood of covering a broader population previously unprotected from vaccine-preventable diseases.

objectiveTo assess the adherence of states and municipalities to OM for HQVA and examine the relationship between adherence levels and increased vaccination coverage in Brazil.

methodsAdopting an epidemiological approach with an ecological design, this study analyzed data on the adherence of the 27 Brazilian federative units to HQVA, as reported through the REDCap electronic form in 2023, as per an agreement with the Ministry of Health. The criteria for assessing the states' adherence to the OM included: (1) Formation of a coordination committee for the OM for HQVA; (2) Inclusion of representatives from Primary Care in the committee; (3) Inclusion of representatives from COSEMS in the committee; (4) Regular coordination meetings between health surveillance and primary care for vaccination actions; and (5) Utilization of a management tool for decision-making and strategic planning (e.g., SWOT). Adherence levels were categorized as: 0 = High adherence (responding positively to 4 or 5 criteria); 1 = Medium adherence (3 positive responses); 2 = Low adherence (2 or fewer positive responses). For municipalities, the adherence criteria were similar, excluding the COSEMS representation and focusing on the involvement of primary care representatives.

resultsThe findings indicated that 45.75% of municipalities achieved full adherence, implementing all the evaluated actions. Despite declaring adherence to the OM, ~ 30.68% of municipalities executed two actions, 19.27% only one, and 4.30% none. Among the states, 37.04% showed full adherence by employing all evaluated actions, with 33.33% executing four actions. States with higher adherence levels to the OM also had greater vaccination coverage (VC), particularly in 2023. Municipalities with complete adherence to the OM met the VC objectives for polio (D3), 10-valent pneumococcal (D2), and triple viral (D1) vaccines in 2023. In states with full adherence to the OM, most municipalities achieved the VC targets for all evaluated vaccines in 2023, showing statistical significance for pentavalent (D3), polio (D3), and 10-valent pneumococcal (D2) vaccines.

conclusionThe findings underscore the impact of OM on improving VC in Brazil, demonstrating that its effective implementation is correlated with meeting VC targets, especially in states and municipalities that enacted all recommended actions. Municipalities engaging in all OM actions met VC objectives for crucial vaccines, highlighting the OM's positive influence on VC. Full adherence to the OM by states correlated with a notable rise in VC averages across all analyzed vaccines. This analysis suggests that higher adherence to OM improves VC outcomes, emphasizing the role of OM in these metrics and shows that comprehensive implementation of OM improves vaccination efforts and significantly boosts VC, particularly in states fully adhering to guidelines.

Indexed as

Guideline AdherenceImmunization ProgramsVaccinationVaccination CoverageBrazilCitiesHumansBrazilMicroplanningVaccinationVaccination coverage

Identifiers

PMID39827108
PMCPMC11748595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.